With its shares near their 52-week low thanks to weak earnings and fears of medical research spending cuts, Thermo Fisher Scientific (TMO) has authorized a new $750M stock buyback plan, good for over 4% of outstanding shares at their current price. The lab equipment maker has only $25M left on an existing authorization.
With its shares near their 52-week low thanks to weak earnings and fears of medical research...
From other sites
Video at CNBC.com (Jun 28, 2016)
Video at CNBC.com (May 27, 2016)
Video at CNBC.com (Apr 7, 2016)
at CNBC.com (Nov 5, 2014)
at CNBC.com (Oct 22, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs